Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?
Tortosa-Carreres J, Cubas-Núñez L, Piqueras M, Castillo-Villalba J, Quintanilla-Bordàs C, Quiroga-Varela A, Villarrubia N, Monreal E, Álvarez G, Gasque-Rubio R, Forés-Toribio L, Carratalà-Boscà S, Lucas C, Sanz MT, Ramió-Torrentà L, Villar LM, Casanova B, Laiz B, Pérez-Miralles FC.
Tortosa-Carreres J, et al. Among authors: sanz mt.
J Neuroimmunol. 2024 Sep 15;394:578428. doi: 10.1016/j.jneuroim.2024.578428. Epub 2024 Aug 3.
J Neuroimmunol. 2024.
PMID: 39121816